[1]
Marra, G., Meseure, D., Lefèvre, M., Nicolas, A., Lesage, L., Ghinea, N., Moschini, M., Pasquali, C., Macek, P., Filippini, C., Gontero, P., Sanchez-Salas, R. and Cathelineau, X. 2022. CD34 and FSHR Expression to Differentiate Multiple Subtypes of Benign and Malignant Renal Neoplasms. Société Internationale d’Urologie Journal. 3, 3 (May 2022), 132-143. DOI:https://doi.org/10.48083/10.48083/RQBN1626.